adamfeuerstein
My second story on #ASCO12 data, focused on $PFE $GSK $JNJ (Zytiga). The latter impressive, bodes well for $MDVN http://t.co/hjlmWxAE
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.